内镜下第三脑室造瘘术治疗弥漫性内生性桥脑胶质瘤相关脑积水的安全性与有效性:一项系统综述
该系统综述遵循PRISMA声明并在PROSPERO注册(CRD42018089001),检索MEDLINE、Web of Knowledge和EMBASE,纳入6项研究并加入本中心2例病例,共55例患者接受内镜下第三脑室造瘘术(ETV)、脑室腹腔分流术(VPS)或Torkildsen脑室脑池分流术。86%的ETV患者术后临床改善(P=0.03),Torkildsen分流失败率为50%,VPS组2例(10%)出现分流功能障碍症状及脑室增大,Fisher精确检验比较VPS与ETV疗效无统计学差异(P=0.17)。作者认为ETV是有效且安全的治疗选择,建议将ETV作为DIPG相关脑积水的首选治疗。
要点
- ETV术后86%患者临床改善(P=0.03),无重大并发症及手术终止。
- Torkildsen分流失败率为50%;VPS组2例(10%)出现分流功能障碍及脑室增大。
- VPS与ETV疗效比较无统计学差异(P=0.17)。
核心结论
- ETV是有效且安全的治疗选择,并发症率低、成功率高。
- 本综述证据建议将ETV作为DIPG相关脑积水的首选治疗。
研究设计与样本
- 系统综述遵循PRISMA声明并在PROSPERO注册(CRD42018089001),检索MEDLINE、Web of Knowledge和EMBASE。
- 纳入6项研究,并加入本中心2例病例,共55例患者接受ETV、VPS或Torkildsen脑室脑池分流术。
主要发现
- 86%接受ETV的患者术后临床改善(P=0.03)。
- Torkildsen分流置入失败率为50%。
- VPS组2例(10%)出现分流功能障碍症状及脑室增大。
- Fisher精确检验比较VPS与ETV疗效无统计学差异(P=0.17)。
- ETV患者未发生重大并发症,未观察到手术终止。
临床怎么用
- 作者认为ETV是有效且安全的治疗选择,建议将ETV作为DIPG相关脑积水的首选治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Diffuse intrinsic pontine glioma (DIPG) related hydrocephalus occurs as the result of tumor growth and sylvian aqueduct obstruction. There is no consensus about the best surgical option; thus, a review has been performed to clarify the rate of success, complications, and possible issues of endoscopic third ventriculostomy (ETV) in comparison to other available techniques. METHODS: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, and was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42018089001). MEDLINE, Web of Knowledge, and EMBASE were searched for published series in which ETV was performed to treat hydrocephalus in DIPG patients. RESULTS: Six studies were included. Two further cases from our experience were added for a total amount of 55 patients treated through either ETV, ventriculoperitoneal shunt (VPS), or ventriculocisternal shunt according to Torkildsen. Eighty-six percent of patients who underwent ETV experienced clinical improvement after surgery (P value 0.03). Torkildsen shunt placement was associated with a 50% failure rate. Two patients implanted with VPS developed symptoms of shunt malfunction and increased ventricular sizes (10%). The Fisher exact test was applied to compare efficacy of VPS and ETV with no statistical difference between the 2 groups (P value 0.17). Patients who underwent ETV did not experience major complications, and no procedural termination was observed. CONCLUSIONS: ETV is an effective and safe treatment option, associated with a low complication rate and a high success rate. Evidences from this review suggest considering ETV as the first-line treatment of hydrocephalus in DIPG patients.
引用
- Guida L, Roux FE, Massimino M, et al. Safety and Efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma Related Hydrocephalus: A Systematic Review. World Neurosurg. 2018. PMID: 30599251. doi:10.1016/j.wneu.2018.12.096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。